Table 3.
Adjusted 10-year Overall and Prostate Cancer-Specific Survival according to Tumor Stage in Men Undergoing Radical Prostatectomy with Adjuvant Radiotherapy versus Radiotherapy plus Androgen Deprivation Therapy
| Tumor Stage | Radical Prostatectomy with Adjuvant Radiotherapy |
Radiotherapy and Androgen Deprivation Therapy | Difference (95% CI) | ||
|---|---|---|---|---|---|
| Event rate per thousand |
Adjusted Survival(%) |
Event rate per thousand |
Adjusted Survival(%) | ||
| 10-year Prostate Cancer-Specific Survival | |||||
| T3a-bN0-XM0 | 1.3 | 88.9 | 2.0 | 74.2 | 14.7(11.4,17.2) |
| T3a-bN1M0 | 2.2 | 75.7 | 3.7 | 58.6 | 17.1(−0.8,34.2) |
| T4N0-XM0 | 2.0 | 72.0 | 4.6 | 60.5 | 11.6(0.8,16.9) |
| T4N1M0 | 3.5 | NA | 8.0 | NA | NA |
| 10-year Overall Survival | |||||
| T3a-bN0-XM0 | 3.4 | 64.2 | 5.3 | 48.3 | 15.8(11.3,20.2) |
| T3a-bN1M0 | 5.6 | 44.3 | 6.5 | 40.5 | 3.8(−10.8,22.5) |
| T4N0-XM0 | 4.0 | 49.6 | 8.8 | 34.9 | 14.7(−0.1,30.5) |
| T4N1M0 | 7.8 | NA | 9.0 | NA | NA |
Note: Covariates included age, race, year of diagnosis, marital status, comorbidity status, income quartiles, urban residence, SEER region, education quartiles, population quartiles. 95% CIS are bootstrapped. 10-year survival was not available in stage T4N1M0 men.